Interview: Dave O’Neil – Vice President & General Manager, Zimmer Biomet, Canada

Referring to the Canadian affiliate of Zimmer Biomet as a “trailblazer”, Dave O’Neil looks back on a successful 2017 for the musculoskeletal healthcare company in Canada. He describes how Zimmer Biomet positions itself as a true partner in driving efficiency in the Canadian healthcare system. 2017 was an eventful year globally for Zimmer Biomet with the appointment of Bryan Hanson as new CEO. What were the main highlights for Zimmer Biomet locally in Canada?
"After the official merger of Zimmer and Biomet in June 2015, the Canadian affiliate was the first affiliate to be fully integrated last year."
Become a PharmaBoardroom Member for free to access this content
Join the 20,000+ pharmaceutical professionals who already subscribe to PharmaBoardroom
Register
Already a member? Sign In

Related Interviews

Latest Report